• Je něco špatně v tomto záznamu ?

Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release

A. Franc, D. Sabadková, D. Neumann, S. Pavloková, P. Kopecká, J. Muselík,

. 2016 ; 21 (7) : 867-874. [pub] 20150831

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014261

Grantová podpora
NT14479 MZ0 CEP - Centrální evidence projektů

Patients tend to evade the occurrence of hypoglycemic episodes by excessive carbohydrate intake. Glucose pellets with delayed release in the time of the maximum effect of insulin can not only prevent hypoglycemia but also eliminate the preventive carbohydrate intake. The pellets can be administered in a mixture with semisolid food. The cores containing glucose in combination with osmotically active agents (croscarmellose sodium, carmellose sodium, polyethylene glycol, or carboxymethyl starch) were prepared by extrusion-spheronization and coated with 15% water ethylcellulose dispersion (Surelease® B NF) in Wurster column (Medipo, Havlíčkův Brod, Czech Republic) into four coating levels (12.5, 25, 35, and 50%). Mean particle size is 0.63-0.73 for cores and 0.82-0.98 for coated pellets. Cores and coated pellets have excellent or good flow properties according to Hausner ratio and Carr index. Aspect ratio ranges from 1.78 to 2.17 for cores and from 1.73 to 2.31 for coated pellets. Dissolution was performed using pH-independent method and method with continual change of pH. The suitable pH-independent release was achieved in the samples containing carboxymethyl starch or polyethylene glycol. Glucose release is enabled by a membrane rupture caused by core swelling. It can be, therefore, assumed that the glucose release profile will not be affected by food or transit time.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014261
003      
CZ-PrNML
005      
20190517105114.0
007      
ta
008      
170413s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.3109/10837450.2015.1073741 $2 doi
035    __
$a (PubMed)26334252
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Franc, Aleš, $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $d 1968- $7 mzk2008479726
245    10
$a Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release / $c A. Franc, D. Sabadková, D. Neumann, S. Pavloková, P. Kopecká, J. Muselík,
520    9_
$a Patients tend to evade the occurrence of hypoglycemic episodes by excessive carbohydrate intake. Glucose pellets with delayed release in the time of the maximum effect of insulin can not only prevent hypoglycemia but also eliminate the preventive carbohydrate intake. The pellets can be administered in a mixture with semisolid food. The cores containing glucose in combination with osmotically active agents (croscarmellose sodium, carmellose sodium, polyethylene glycol, or carboxymethyl starch) were prepared by extrusion-spheronization and coated with 15% water ethylcellulose dispersion (Surelease® B NF) in Wurster column (Medipo, Havlíčkův Brod, Czech Republic) into four coating levels (12.5, 25, 35, and 50%). Mean particle size is 0.63-0.73 for cores and 0.82-0.98 for coated pellets. Cores and coated pellets have excellent or good flow properties according to Hausner ratio and Carr index. Aspect ratio ranges from 1.78 to 2.17 for cores and from 1.73 to 2.31 for coated pellets. Dissolution was performed using pH-independent method and method with continual change of pH. The suitable pH-independent release was achieved in the samples containing carboxymethyl starch or polyethylene glycol. Glucose release is enabled by a membrane rupture caused by core swelling. It can be, therefore, assumed that the glucose release profile will not be affected by food or transit time.
650    _2
$a celulosa $x analogy a deriváty $x chemie $7 D002482
650    _2
$a farmaceutická chemie $x metody $7 D002626
650    _2
$a dítě $7 D002648
650    _2
$a léky s prodlouženým účinkem $x aplikace a dávkování $x chemie $7 D003692
650    _2
$a diabetes mellitus $x farmakoterapie $7 D003920
650    _2
$a lékové formy $7 D004304
650    _2
$a lékové transportní systémy $x metody $7 D016503
650    _2
$a implantované léky $x aplikace a dávkování $7 D004343
650    _2
$a pomocné látky $x chemie $7 D005079
650    _2
$a glukosa $x aplikace a dávkování $7 D005947
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemie $x farmakoterapie $7 D007003
650    _2
$a hypoglykemika $x aplikace a dávkování $7 D007004
650    _2
$a velikost částic $7 D010316
650    _2
$a polyethylenglykoly $x chemie $7 D011092
650    _2
$a rozpustnost $7 D012995
650    _2
$a škrob $x analogy a deriváty $x chemie $7 D013213
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sabadková, Dana $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 _AN080394
700    1_
$a Neumann, David, $u Department of Pediatrics , University Hospital , Hradec Králové , Czech Republic. $d 1973- $7 xx0079752
700    1_
$a Pavloková, Sylvie $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 xx0238422
700    1_
$a Kopecká, Pavlína $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 _AN087079
700    1_
$a Muselík, Jan $u Department of Pharmaceutics, Faculty of Pharmacy , University of Veterinary and Pharmaceutical Sciences , Brno , Czech Republic and. $7 xx0100243
773    0_
$w MED00004889 $t Pharmaceutical development and technology $x 1097-9867 $g Roč. 21, č. 7 (2016), s. 867-874
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26334252 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20190517105223 $b ABA008
999    __
$a ok $b bmc $g 1200726 $s 975039
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 21 $c 7 $d 867-874 $e 20150831 $i 1097-9867 $m Pharmaceutical development and technology $n Pharm Dev Technol $x MED00004889
GRA    __
$a NT14479 $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...